Valuation: genOway

Market Cap 23.7M 27.03M 21.9M 20.14M 38.01M 2.61B 38.62M 262M 103M 1.28B 102M 99.3M 4.39B P/E 2024 *
-
P/E 2025 -
Enterprise Value 30.41M 34.7M 28.11M 25.86M 48.79M 3.35B 49.57M 336M 132M 1.64B 130M 127M 5.64B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day-3.50%
1 week+4.20%
Current month+4.64%
1 month+3.33%
3 months-0.80%
6 months-0.80%
Current year-8.49%
1 week 2.28
Extreme 2.28
2.63
1 month 2.21
Extreme 2.21
2.63
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
1/20/22 Buy

Chief Executive Officer

12,500 0.1376%
11/17/21 Sell

Chief Executive Officer

5,000 0.0553%
11/13/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%+4.20%-20.00%-35.42% 27.12M
-0.49%-4.01%+0.61%+2.28% 49.18B
-0.62%+0.54%+381.39%+589.60% 39.58B
+0.36%+2.68%+6.92%+61.81% 34.69B
-0.55%-1.08%+29.15%-9.31% 34.42B
-1.82%-1.48%+0.52%+32.02% 27.11B
-1.83%-3.25% - - 16.21B
-0.53%+0.99%+73.35%+116.87% 15.36B
+1.17%+2.30%+15.46%+18.26% 14.05B
-2.28%+0.18%+19.17%-32.74% 13.02B
Average -0.97%+0.55%+56.28%+82.60% 24.37B
Weighted average by Cap. -0.56%-0.38%+79.03%+122.07%

Financials

2024 2025
Net sales 27.53M 31.41M 25.45M 23.41M 44.16M 3.03B 44.87M 304M 119M 1.48B 118M 115M 5.11B 28.6M 32.63M 26.44M 24.31M 45.88M 3.15B 46.61M 316M 124M 1.54B 123M 120M 5.3B
Net income 1.83M 2.09M 1.69M 1.56M 2.94M 201M 2.98M 20.23M 7.93M 98.55M 7.84M 7.67M 340M 928K 1.06M 858K 789K 1.49M 102M 1.51M 10.25M 4.02M 49.94M 3.97M 3.89M 172M
Net Debt 623K 711K 576K 530K 999K 68.54M 1.02M 6.89M 2.7M 33.54M 2.67M 2.61M 116M 6.72M 7.66M 6.21M 5.71M 10.78M 739M 10.95M 74.25M 29.11M 362M 28.78M 28.15M 1.25B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-07-20 2.480 -3.50% 18,831
26-07-17 €2.570 -1.53% 5,141
26-07-16 €2.610 +9.66% 165,788
26-07-15 €2.380 +1.71% 4,094
26-07-14 €2.340 -1.68% 1,572
  1. Stock Market
  2. Stocks
  3. ALGEN Stock